Skip to content
Healthy Aging Hub

:

Articles related to focusing on healthy aging, prevention, mobility, cognition, nutrition, independence, and caregiving support.

4 min

When was denosumab first used? A Look into Its Groundbreaking History

Denosumab was first approved by the U.S. Food and Drug Administration (FDA) in 2010, marking a significant milestone in the treatment of osteoporosis and other bone-related conditions. This pivotal moment followed years of research and clinical trials, leading to a new class of medication for senior care. Understanding **when was denosumab first used** reveals the evolution of bone health treatments.

Read Healthy Aging
3 min

How long has denosumab been on the market?

Denosumab first received U.S. Food and Drug Administration (FDA) approval for its osteoporosis brand name, Prolia, on June 1, 2010. Since then, denosumab has also been approved under the brand name Xgeva for oncology-related indications, with its first approval coming later in 2010.

Read Healthy Aging